Atherosclerosis and Lipoproteins |
From the Department of Pathology (J.F., H. Shimoyamada, H. Sun, T.W.), Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan; Northwest Lipid Research Laboratories (S.M.), University of Washington, Seattle; and the Research Institute of Yamonouchi Pharmaceutical Company (K.H.), Tsukuba, Japan.
Correspondence to Jianglin Fan, MD, PhD, Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba 305-8575, Japan. E-mail J-LFAN{at}md.tsukuba.ac.jp
AbstractHigh lipoprotein(a) [Lp(a)] levels constitute an independent risk factor for the development of atherosclerosis. However, the relationship between Lp(a) and atherosclerosis is not fully understood. To examine the effect of Lp(a) on the development of atherosclerosis, we studied transgenic rabbits expressing human apolipoprotein(a) [apo(a)], which was assembled into Lp(a) in the plasma. Human apo(a) transgenic rabbits fed a 0.3% cholesterol diet for 16 weeks had more extensive atherosclerotic lesions than did nontransgenic rabbits, although the cholesterol levels in the plasma of both groups were similarly elevated. Compared with the lesions in control rabbits, the areas of the atherosclerotic lesions in human apo(a) transgenic rabbits were significantly increased in the aorta, the iliac artery, and the carotid artery. Furthermore, human apo(a) transgenic rabbits on a cholesterol-rich diet had a greater degree of coronary atherosclerosis than did control rabbits. Immunohistochemical analysis revealed that human apo(a) was frequently deposited in the atherosclerotic lesions of transgenic rabbits. We conclude that Lp(a) may have proatherogenic effects in the setting of a cholesterol-rich diet in transgenic rabbits.
Key Words: apolipoproteins atherosclerosis lipoproteins transgenic rabbits
This article has been cited by other articles:
![]() |
J. Hoover-Plow, E. Hart, Y. Gong, A. Shchurin, and T. Schneeman A Physiological Function for Apolipoprotein(a): A Natural Regulator of the Inflammatory Response Experimental Biology and Medicine, January 1, 2009; 234(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashimoto, M. Kihara, N. Imai, S.-i. Yoshida, H. Shimoyamada, H. Yasuzaki, J. Ishida, Y. Toya, Y. Kiuchi, N. Hirawa, et al. Requirement of Apelin-Apelin Receptor System for Oxidative Stress-Linked Atherosclerosis Am. J. Pathol., November 1, 2007; 171(5): 1705 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, T. Koike, T. Ichikawa, K. Hatakeyama, M. Shiomi, B. Zhang, S. Kitajima, M. Morimoto, T. Watanabe, Y. Asada, et al. C-Reactive Protein in Atherosclerotic Lesions: Its Origin and Pathophysiological Significance Am. J. Pathol., October 1, 2005; 167(4): 1139 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, H. Sun, T. Watanabe, G. Liu, and J. Fan Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase Cardiovasc Res, February 1, 2005; 65(2): 524 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Berglund and R. Ramakrishnan Lipoprotein(a): An Elusive Cardiovascular Risk Factor Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2219 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, G. Liu, H. Sun, S. Kitajima, M. Morimoto, T. Watanabe, et al. Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity J. Biol. Chem., February 27, 2004; 279(9): 7521 - 7529. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions Clin. Chem., November 1, 2003; 49(11): 1785 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Muller, A. S. Lindman, A. Blomfeldt, I. Seljeflot, and J. I. Pedersen A Diet Rich in Coconut Oil Reduces Diurnal Postprandial Variations in Circulating Tissue Plasminogen Activator Antigen and Fasting Lipoprotein (a) Compared with a Diet Rich in Unsaturated Fat in Women J. Nutr., November 1, 2003; 133(11): 3422 - 3427. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tsurupa, B. Ho-Tin-Noe, E. Angles-Cano, and L. Medved Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) {alpha}C-domains J. Biol. Chem., September 26, 2003; 278(39): 37154 - 37159. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, H. Unoki, X. Wang, J. Liang, T. Ichikawa, Y. Arai, M. Shiomi, S. M. Marcovina, T. Watanabe, and J. Fan Lipoprotein(a) Enhances Advanced Atherosclerosis and Vascular Calcification in WHHL Transgenic Rabbits Expressing Human Apolipoprotein(a) J. Biol. Chem., November 27, 2002; 277(49): 47486 - 47492. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ichikawa, H. Unoki, H. Sun, H. Shimoyamada, S. Marcovina, H. Shikama, T. Watanabe, and J. Fan Lipoprotein(a) Promotes Smooth Muscle Cell Proliferation and Dedifferentiation in Atherosclerotic Lesions of Human Apo(a) Transgenic Rabbits Am. J. Pathol., January 1, 2002; 160(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fan, H. Unoki, N. Kojima, H. Sun, H. Shimoyamada, H. Deng, M. Okazaki, H. Shikama, N. Yamada, and T. Watanabe Overexpression of Lipoprotein Lipase in Transgenic Rabbits Inhibits Diet-induced Hypercholesterolemia and Atherosclerosis J. Biol. Chem., October 19, 2001; 276(43): 40071 - 40079. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishibashi Lipoprotein(a) and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 1 - 2. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |